MedMind

Health systems are juggling dozens of apps, incompatible devices, and an unmanageable number of EMR integrations that don’t talk to each other. This lack of integration creates inefficiencies, drains resources, and frustrates everyone involved. Enter MedMind https://lnkd.in/gFz4wFkd

MedMind is a online health platform for people to be able to order their medications and access information about them easily and affordably. Check us out!

https://lnkd.in/g4s72Wum

While the former Biden administration showcased the Inflation Reduction Act as a key victory in the fight over high drug prices in the U.S., Trump has so far been mum on how the controversial law could evolve in the coming years. https://lnkd.in/g4s72Wum

The question isn’t just “How will AI impact healthcare?” It’s “How quickly can healthcare systems adapt to these revolutionary changes?“ https://lnkd.in/gN3R_GCe

Tyson shares how leveraging strategic partnerships like Mark Cuban Cost Plus Drug Company, PBC has transformed their approach to pharmacy management. ????????-???????????? ??????????????: By leveraging data analytics, MultiCare identified Mark Cuban Cost Plus Drugs as a disruptive partner to bypass traditional middlemen like wholesalers and GPOs. This approach saved over $1 million in just six months, allowing reinvestment in patient care and innovation. 340?? ?????? ???????????? ??????????????: MultiCare's 12 retail pharmacies—half operating under 340B—have benefited significantly. Through careful analysis of WAC spend and Mark Cuban's pricing catalog, they optimized drug purchasing, turning cost efficiencies into accumulations for 340B purchases. ???????????????? ????????????????????: Tyson emphasized MultiCare’s commitment to forward-thinking strategies, automation, and direct partnerships to navigate disruptions like supply chain challenges and inflation. Thank you, Tyson, for sharing! More of this conversation will be released very soon! Stay tuned.

?? Breaking New Ground in Longevity Research Novartis and BioAge Labs have joined forces in an exciting partnership focused on identifying new drug targets for longevity and exercise benefits. This collaboration underscores the growing emphasis on proactive health interventions and aging-related therapies. As the global population ages, initiatives like this highlight the potential to redefine aging—not just as a natural process but as an opportunity to extend vitality and quality of life. At MedMind , we're passionate about innovations that challenge traditional boundaries in healthcare and push the envelope on what’s possible for human well-being. Partnerships like Novartis and BioAge pave the way for integrating cutting-edge science into practical solutions for healthier, longer lives. How do you see this evolving field of longevity impacting healthcare in the coming years? Let's discuss below! ?? https://lnkd.in/gh8-kDWn #LongevityResearch #HealthcareInnovation #MedMind #AIInHealthcare

? Drug Price Hikes Under Scrutiny ? The U.S. drug pricing watchdog ICER recently flagged five major pharmaceutical companies for "unjustified price increases" on several key medications. These hikes, which lack evidence of clinical improvement, are driving up costs for patients and the healthcare system. Some of the notable drugs called out include: ? AbbVie's Humira – a critical treatment for autoimmune conditions. ? Bayer's Nubeqa – a prostate cancer therapy. ICER’s report highlights the growing debate around balancing innovation with affordability. Patients and healthcare stakeholders are calling for greater transparency and accountability when it comes to pricing decisions. As the industry faces increasing scrutiny, the question remains: How can we ensure fair access to life-saving medications while fostering innovation? At MedMind, we continue to track these critical developments and explore how policy, innovation, and pricing align to impact healthcare delivery. https://lnkd.in/gS6ThXhe #DrugPricing #PharmaNews #HealthcareInnovation #MedMind #PatientAccess #LifeSciences

?? The Future of Drug Delivery: Smarter, Targeted, and More Effective! ?? At MedMind, we're excited to see how advancements in drug delivery are transforming the medical landscape. Recent innovations are making drugs "smarter," enabling precise targeting to affected areas in the body while minimizing side effects. Technologies like nano-carriers, implantable devices, and AI-driven delivery systems are revolutionizing treatment options for patients across various conditions. ?? What's Changing??? - Targeted Delivery: New technologies enable drugs to be directed to specific cells, reducing impact on healthy tissue. - Controlled Release: Implantable devices and nano-carriers allow for a gradual release, improving therapeutic outcomes. - Personalization: Leveraging AI, treatments are now more tailored, aligning with each patient's unique needs. As smart drug delivery evolves, the future of medicine holds even greater promise. At MedMind, we remain committed to exploring these groundbreaking solutions, driving better health outcomes for patients everywhere. https://lnkd.in/eGVTDwEd #MedMind #DrugDelivery #SmartDrugs #AIinHealthcare #Innovation

AI-driven technology like Chartwatch is transforming healthcare, as shown by a recent study at St. Michael's Hospital in Toronto. This AI-based early warning system monitors patient vitals and lab results, flagging potential health crises before visible symptoms appear. When it detected a high white blood cell count in a patient who seemed stable, staff acted swiftly to treat cellulitis, a potentially severe bacterial infection. The study revealed a 26% drop in unexpected deaths with Chartwatch's use, showing AI's vital role in enhancing clinical decision-making and patient outcomes. https://lnkd.in/gmxQUyGr #HealthcareAI #PatientCare #Innovation